Carmell (NASDAQ:CTCX) Shares Down 2.8% - Here's Why

Carmell Co. (NASDAQ:CTCX - Get Free Report)'s stock price dropped 2.8% on Thursday . The stock traded as low as $2.38 and last traded at $2.45. Approximately 18,767 shares traded hands during trading, a decline of 100% from the average daily volume of 4,290,529 shares. The stock had previously closed at $2.52.Carmell Stock PerformanceThe firm has a 50 day moving average of $2.05 and a two-hundred day moving average of $0.89. Institutional Trading of CarmellA hedge fund recently bought a new stake in Carmell stock. Citadel Advisors LLC bought a new stake in shares of Carmell Co. (NASDAQ:CTCX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 187,565 shares of the company's stock, valued at approximately $54,000. Citadel Advisors LLC owned 0.90% of Carmell as of its most recent SEC filing. Institutional investors own 24.22% of the company's stock. About Carmell (Get Free Report)Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.Read MoreFive stocks we like better than CarmellWhat Are the U.K. Market Holidays? How to Invest and TradeRigetti Computing: Cantor's Bullish Call May Be Just the StartIndustrial Products Stocks Investing Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo LeadHow to Invest in the Best Canadian Stocks 3 Top Stocks Under $20 Riding the “Made in America” WaveThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Carmell Right Now?Before you consider Carmell, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carmell wasn't on the list.While Carmell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here